341 related articles for article (PubMed ID: 19860563)
1. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1186-92. PubMed ID: 19860563
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
3. An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis.
Jamulitrat S; Thongpiyapoom S; Suwalak N
J Med Assoc Thai; 2007 Oct; 90(10):2181-91. PubMed ID: 18041440
[TBL] [Abstract][Full Text] [Related]
4. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
Lee HY; Huang CW; Chen CL; Wang YH; Chang CJ; Chiu CH
J Microbiol Immunol Infect; 2015 Dec; 48(6):588-96. PubMed ID: 26055692
[TBL] [Abstract][Full Text] [Related]
5. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Jamulitrat S; Arunpan P; Phainuphong P
J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
[TBL] [Abstract][Full Text] [Related]
6. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes.
Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
Infect Control Hosp Epidemiol; 2010 Jan; 31(1):47-53. PubMed ID: 19951202
[TBL] [Abstract][Full Text] [Related]
7. Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit.
Hong KB; Oh HS; Song JS; Lim JH; Kang DK; Son IS; Park JD; Kim EC; Lee HJ; Choi EH
Pediatr Infect Dis J; 2012 Jul; 31(7):685-90. PubMed ID: 22466324
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.
Katragkou A; Kotsiou M; Antachopoulos C; Benos A; Sofianou D; Tamiolaki M; Roilides E
Intensive Care Med; 2006 Sep; 32(9):1384-91. PubMed ID: 16788807
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
Dizbay M; Tunccan OG; Sezer BE; Hizel K
Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
[TBL] [Abstract][Full Text] [Related]
10. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
[TBL] [Abstract][Full Text] [Related]
11. A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China.
Ye D; Shan J; Huang Y; Li J; Li C; Liu X; He W; Li Y; Mao P
BMC Infect Dis; 2015 Apr; 15():179. PubMed ID: 25886493
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in a burn unit: An appraisal of the effect of colonization pressure.
Cavalcante Rde S; Canet P; Fortaleza CM
Scand J Infect Dis; 2014 Aug; 46(8):593-8. PubMed ID: 24918115
[TBL] [Abstract][Full Text] [Related]
13. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
Lemos EV; de la Hoz FP; Alvis N; Einarson TR; Quevedo E; Castañeda C; Leon Y; Amado C; Cañon O; Kawai K
Clin Microbiol Infect; 2014 Feb; 20(2):174-80. PubMed ID: 23668595
[TBL] [Abstract][Full Text] [Related]
14. Correlation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010.
Tan CK; Tang HJ; Lai CC; Chen YY; Chang PC; Liu WL
J Microbiol Immunol Infect; 2015 Oct; 48(5):540-4. PubMed ID: 24685280
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.
Lee SO; Kim NJ; Choi SH; Hyong Kim T; Chung JW; Woo JH; Ryu J; Kim YS
Antimicrob Agents Chemother; 2004 Jan; 48(1):224-8. PubMed ID: 14693543
[TBL] [Abstract][Full Text] [Related]
16. The Changes in Epidemiology of Imipenem-Resistant
Kim D; Lee H; Choi JS; Croney CM; Park KS; Park HJ; Cho J; Son S; Kim JY; Choi SH; Huh HJ; Ko KS; Lee NY; Kim YJ
J Korean Med Sci; 2022 Jun; 37(24):e196. PubMed ID: 35726147
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit.
Young LS; Sabel AL; Price CS
Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1247-54. PubMed ID: 17926275
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of an outbreak of imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla(OXA-51-like) genes in a Korean hospital.
Chaulagain BP; Jang SJ; Ahn GY; Ryu SY; Kim DM; Park G; Kim WY; Shin JH; Kook JK; Kang SH; Moon DS; Park YJ
Jpn J Infect Dis; 2012; 65(2):162-6. PubMed ID: 22446125
[TBL] [Abstract][Full Text] [Related]
19. Outbreak of imipenem-resistant Acinetobacter baumannii in different wards at a regional hospital related to untrained bedside caregivers.
Wang CH; Li JF; Huang LY; Lin FM; Yang YS; Siu LK; Chang FY; Lin JC
Am J Infect Control; 2017 Oct; 45(10):1086-1090. PubMed ID: 28549878
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates.
Lee HY; Hsu SY; Hsu JF; Chen CL; Wang YH; Chiu CH
J Microbiol Immunol Infect; 2018 Jun; 51(3):367-376. PubMed ID: 28830746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
